vimarsana.com
Home
Live Updates
FDA Approves Shorter Manufacturing Process for CAR T-cell Th
FDA Approves Shorter Manufacturing Process for CAR T-cell Th
FDA Approves Shorter Manufacturing Process for CAR T-cell Therapy Axicabtagene Ciloleucel
Less manufacturing time could be the difference between a patient receiving this life-saving therapy vs not.
Related Keywords
United States ,
Cindy Perettie ,
Chris Mcdonald ,
David Miklos ,
Cell Therapy At Stanford University ,
Marrow Transplant ,
Cell Therapy ,
Stanford University ,